Glioma cells actively suppress immune surveillance through multiple mechanisms, including the downregulation of MHC molecules, recruitment of regulatory immune populations, expression of immune checkpoint ligands, and secretion of immunosuppressive cytokines [6]. The gene discussed is HLA-C; the disease is central nervous system cancer.